SE for moderate hyperopia was: hyperopia SE [greater than or equal to] +2.
Heredity was dichotomized whereby hyperopia was considered to have been inherited when both students' parents wore glasses and had started to wear them before they were 40 years old.
Moderate hyperopia prevalence was around 9% among children and adolescents aged 12 or older (Table 2).
Examination of the crude analysis revealed no statistically significant association between moderate hyperopia and heredity, economic level, playing outside, playing sports, watching TV and playing computer or video games.
Examination of the association between moderate hyperopia and independent variables showed, after adjustment for confounding factors, that girls were 39% more hyperopic than boys RP = 1.
However, in hyperopia there are several unique considerations.
Hyperopic excimer laser refractive surgery relies on laser pulses applied in an annulus around the mid corneal periphery in order to induce central corneal steepening, increase corneal power thereby reducing hyperopia (see Figure 1).
LASIK remains the treatment of choice in patients with low hyperopia who are not yet presbyopic providing patients fulfil the standard safety criteria for laser vision correction such as a normal corneal topography and an adequate tear film.
In a prospective study of US naval aviators, 25 eyes underwent LASIK for hyperopia with the VISX S4 (Abbott Medical Optics, Abbott Park, Illinois, US).
A six-month evaluation of clinical study participants showed that more than four times as many people were very satisfied with their night vision after the VISX CustomVue Hyperopia procedure, compared to their night vision before with glasses or contacts.
Forward-looking statements in this release, including statements about the quality of the CustomVue Hyperopia procedure, including that CustomVue has the potential to deliver better vision than contacts or glasses, and that CustomVue Hyperopia will enhance our market leadership position, drive CustomVue conversions, and increase future revenue and profit are based on information available to the Company as of the date hereof.
Primary product lines include ARTISAN(R) Myopia Lenses, ARTISAN(R) Hyperopia
Lenses, ARTISAN(R) Toric Lenses, ARTISAN(R) Pediatric Lenses, ARTIFLEX(TM) Foldable Phakic Lenses, OPHTEC Capsular Tension Rings, Custom Artificial Iris Implants and the IPS(TM) Iris Prosthetic System.